substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with substance p, arg(1)-pro(2)-trp(7,9)-leu(11)- in 1 studies
Studies (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Trials (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Recent Studies (post-2010) (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-) | Studies (substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-) | Trials (substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-) | Recent Studies (post-2010) (substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-) |
---|---|---|---|---|---|
20 | 0 | 1 | 22 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rozengurt, E; Woll, PJ | 1 |
1 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and substance p, arg(1)-pro(2)-trp(7,9)-leu(11)-
Article | Year |
---|---|
A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Topics: Animals; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; Cells, Cultured; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Peptide Fragments; Peptides; Recombinant Proteins; Substance P; Tumor Cells, Cultured; Vasopressins | 1990 |